Sensex snaps 3-day losing streak; up 22.44 points led by RIL,ONGC

June 05, 2013 04:43 pm | Updated November 16, 2021 08:45 pm IST - Mumbai

NEW DELHI:  BSE SENSEX/ NSE NIFTY.  PTI GRAPHICS (PTI6_5_2013_000093B)

NEW DELHI: BSE SENSEX/ NSE NIFTY. PTI GRAPHICS (PTI6_5_2013_000093B)

Rising for the first time in four days, the BSE benchmark Sensex on Wednesday gained 22.44 points buoyed by gains in bluechips RIL, ONGC and Sun Pharma.

The 30-share index rose by 22.44 points, or 0.11 per cent, to 19,568.22. It had lost 670 points in the last three sessions.

Similarly, the broad-based National Stock Exchange index Nifty closed higher by 4.40 points, or 0.07 per cent, at 5,923.85.

Also, MCX-SX flagship index, SX40, ended up by 5.77 points, or 0.05 per cent, at 11,615.84.

Brokers said investors bought fundamentally strong stocks such as Reliance Industries, Sun Pharma and Larsen and Toubro at prevailing lower levels following three days of losses.

While Reliance Industries, a heavy-weight on Sensex climbed 2.56 per cent to Rs 800.55 ahead of its annual general meeting, Sun Pharma rose 1.91 per cent to Rs 1,038.30 after Sweden’s Meda denied reports of stake sale.

ONGC gained 1.95 per cent to Rs 324.55.

Meanwhile, Just Dial on Wednesday made a smart debut on the bourses, listing with a gain of 12.61 per cent at Rs 611.45, after touching a high of 19 per cent against its issue price of Rs 530.

Out of the 30 BSE shares, 18 stocks were up led by RIL, ONGC and Sun Pharma, while IT majors Wipro and Infosys were the biggest losers falling 1.59 per cent and 1.32 per cent, respectively.

The oil and gas sector index rose the most by 1.77 per cent to 8,626.47 followed by realty and metal sector indices.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.